Lilly Korea raises some questions over VA drug guideline

Published: 2002-09-12 06:59:00

Updated: 2002-09-12 06:59:00

In line with the drug guideline released by the U.S. Veterans Affairs Medical Center that Zyprexa (olanzapine), an anti-psychotic medication, should be designated as the third-line drug, Lilly Korea has complained about their unethical attitude over other competitors without more thoughtful consi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK